Entropy Technologies LP Grows Position in Danaher Co. (NYSE:DHR)

Entropy Technologies LP increased its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 126.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,567 shares of the conglomerate's stock after acquiring an additional 30,464 shares during the period. Danaher comprises approximately 1.3% of Entropy Technologies LP's holdings, making the stock its largest holding. Entropy Technologies LP's holdings in Danaher were worth $12,526,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the fourth quarter worth $31,000. Teachers Insurance & Annuity Association of America acquired a new position in shares of Danaher during the third quarter valued at $39,000. Finally, MidAtlantic Capital Management Inc. bought a new position in Danaher in the third quarter valued at about $40,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.3 %

Shares of NYSE DHR traded up $0.60 during mid-day trading on Wednesday, hitting $202.22. The company had a trading volume of 7,207,744 shares, compared to its average volume of 4,373,626. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The company has a market capitalization of $146.06 billion, a PE ratio of 38.30, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a 50-day simple moving average of $231.17 and a two-hundred day simple moving average of $250.62.

Remove Ads

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the firm posted $2.09 earnings per share. On average, equities analysts expect that Danaher Co. will post 7.67 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. Danaher's payout ratio is 20.45%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on DHR shares. Royal Bank of Canada reissued an "outperform" rating and set a $277.00 price objective (down from $299.00) on shares of Danaher in a report on Thursday, January 30th. Wolfe Research raised shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 target price for the company in a report on Thursday, October 31st. Robert W. Baird decreased their price objective on Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Stephens restated an "overweight" rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Finally, Guggenheim assumed coverage on Danaher in a research note on Thursday, December 19th. They issued a "buy" rating and a $275.00 price target for the company. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $278.00.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company's stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.